Entheon Biomedical (Entheon Biomedical) EV-to-EBITDA : -4.46 (As of May. 20, 2024)

Entheon Biomedical EV-to-EBITDA Chart

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial															-0.59	-1.52	-2.34	-0.78	-1.21

Competitive Comparison of Entheon Biomedical's EV-to-EBITDA

For the Biotechnology subindustry, Entheon Biomedical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's EV-to-EBITDA falls into.

Entheon Biomedical EV-to-EBITDA Calculation

Entheon Biomedical's EV-to-EBITDA for today is calculated as:

Entheon Biomedical's current Enterprise Value is $0.92 Mil.
Entheon Biomedical's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical  (OTCPK:ENTBF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Entheon Biomedical's PE Ratio for today is calculated as:

Entheon Biomedical's share price for today is $0.131.
Entheon Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.033.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Entheon Biomedical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (Entheon Biomedical) Business Description